IL210696A0 - Methods and systems for evaluating memory agents - Google Patents

Methods and systems for evaluating memory agents

Info

Publication number
IL210696A0
IL210696A0 IL210696A IL21069611A IL210696A0 IL 210696 A0 IL210696 A0 IL 210696A0 IL 210696 A IL210696 A IL 210696A IL 21069611 A IL21069611 A IL 21069611A IL 210696 A0 IL210696 A0 IL 210696A0
Authority
IL
Israel
Prior art keywords
systems
methods
memory agents
evaluating memory
evaluating
Prior art date
Application number
IL210696A
Other versions
IL210696A (en
Original Assignee
Dart Neuroscience Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dart Neuroscience Llc filed Critical Dart Neuroscience Llc
Publication of IL210696A0 publication Critical patent/IL210696A0/en
Publication of IL210696A publication Critical patent/IL210696A/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/15—Medicinal preparations ; Physical properties thereof, e.g. dissolubility
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B30/00—Methods of screening libraries
    • C40B30/06—Methods of screening libraries by measuring effects on living organisms, tissues or cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Neurology (AREA)
  • Food Science & Technology (AREA)
  • Molecular Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
IL210696A 2008-07-18 2011-01-17 Method for assessing the effectiveness of a memory agent administered to a primate in enhancing long term memory IL210696A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8194508P 2008-07-18 2008-07-18
PCT/US2009/051082 WO2010009453A1 (en) 2008-07-18 2009-07-17 Methods and systems for evaluating memory agents

Publications (2)

Publication Number Publication Date
IL210696A0 true IL210696A0 (en) 2011-03-31
IL210696A IL210696A (en) 2014-12-31

Family

ID=41550744

Family Applications (1)

Application Number Title Priority Date Filing Date
IL210696A IL210696A (en) 2008-07-18 2011-01-17 Method for assessing the effectiveness of a memory agent administered to a primate in enhancing long term memory

Country Status (11)

Country Link
EP (1) EP2313098A4 (en)
JP (1) JP5789511B2 (en)
KR (1) KR20110049801A (en)
CN (1) CN102143749A (en)
AU (1) AU2009270697A1 (en)
BR (1) BRPI0916228A2 (en)
CA (1) CA2730940A1 (en)
IL (1) IL210696A (en)
MX (1) MX2011000652A (en)
SG (1) SG195572A1 (en)
WO (1) WO2010009453A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8277842B1 (en) 2012-01-20 2012-10-02 Dart Neuroscience (Cayman) Ltd. Enteric-coated HT-2157 compositions and methods of their use

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6770658B2 (en) * 1998-09-09 2004-08-03 Inflazyme Pharmaceuticals Ltd. Substituted γ-phenyl-Δ-lactams and uses related thereto
EP1161525A2 (en) * 1999-03-12 2001-12-12 Brown University Research Foundation Methods and compositions for regulating memory consolidation
ES2323940T3 (en) * 2000-05-01 2009-07-28 Accera, Inc. USE OF MEDIUM CHAIN TRIGLICERIDS FOR THE TREATMENT AND PREVENTION OF ALZHEIMER'S DISEASE.
US20070179197A1 (en) * 2000-05-01 2007-08-02 Accera, Inc. Compositions and methods for improving or preserving brain function
JP2002020291A (en) * 2000-06-30 2002-01-23 Sumitomo Pharmaceut Co Ltd Therapeutic agent for cognitive dysfunction
WO2002013867A2 (en) * 2000-08-10 2002-02-21 Cold Spring Harbor Laboratory Augmented cognitive training
US20040224316A1 (en) * 2000-08-10 2004-11-11 Tully Timothy P. Augmented cognitive training
EP1551855B1 (en) * 2002-06-25 2012-01-04 Helicon Therapeutics, Inc. Altering memory by affecting staufen function
US7642281B2 (en) * 2002-08-07 2010-01-05 Helicon Therapeutics, Inc. Indolone compounds useful to treat cognitive impairment
AU2003258287A1 (en) * 2002-08-19 2004-03-03 Helicon Therapeutics, Inc. Screening methods for cognitive enhancers
AU2006326040B2 (en) * 2005-12-15 2012-02-09 Société des Produits Nestlé S.A. Compositions and methods for preserving brain function
EP2001293B9 (en) * 2006-04-03 2019-04-17 Accera, Inc. Use of ketogenic compounds for treatment of age-associated memory impairment
SG172602A1 (en) * 2006-05-19 2011-07-28 Helicon Therapeutics Inc Phosphodiesterase 4 inhibitors for cognitive and motor rehabilitation
GB0611458D0 (en) * 2006-06-09 2006-07-19 Univ Cambridge Tech Assessment of functional status
JP2009541493A (en) * 2006-06-26 2009-11-26 ヘリコン セラピューティクス，インコーポレイテッド Method for modulating neurite outgrowth by use of a galanin-3 receptor antagonist

Also Published As

Publication number Publication date
EP2313098A4 (en) 2011-12-21
SG195572A1 (en) 2013-12-30
MX2011000652A (en) 2011-06-16
IL210696A (en) 2014-12-31
AU2009270697A1 (en) 2010-01-21
CN102143749A (en) 2011-08-03
WO2010009453A1 (en) 2010-01-21
JP2011528667A (en) 2011-11-24
EP2313098A1 (en) 2011-04-27
KR20110049801A (en) 2011-05-12
JP5789511B2 (en) 2015-10-07
CA2730940A1 (en) 2010-01-21
BRPI0916228A2 (en) 2015-11-03

Similar Documents

Publication Publication Date Title
HK1216040A1 (en) System and method for evaluating tissue
EP2281065A4 (en) Method for evaluating and comparing immunorepertoires
EP2245541A4 (en) Systems and methods for memory expansion
HK1148098A1 (en) Systems and methods for facilitating consumer-dispenser interactions
EP2308041A4 (en) Systems and methods for concept mapping
EP2310076A4 (en) Anchor systems and methods
ZA200906118B (en) Descenting systems and methods
EP2115594A4 (en) Memory system
EP2250564A4 (en) Memory system
EP2250567A4 (en) Memory system
EP2250565A4 (en) Memory system
EP2250489A4 (en) Systems and methods for providing environment monitoring
EP2248024A4 (en) Memory system
EP2248027A4 (en) Memory system
EP2200977A4 (en) F1f0-atpase inhibitors and related methods
EP2250566A4 (en) Memory system
EP2248022A4 (en) Memory system
EP2248026A4 (en) Memory system
IL202089A0 (en) Systems and methods for organ monitoring
EP2118756A4 (en) Memory system
GB2459741B (en) Debugging system and method
EP2111583A4 (en) Memory system
EP2335208A4 (en) Systems and methods for evaluating advertising metrics
IL213321A0 (en) Descenting systems and methods
GB2485925B (en) Connection methods and systems

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees